Erratum: Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Erratum for Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. [BMC Cancer. 2013]

Volltext
Verfasser: Hendlisz, Alain
Golfinopoulos, Vassilis
Deleporte, Amelie
Paesmans, Marianne
El Mansy, Hazem
Garcia, Camilo
Peeters, Marc
Annemans, Lieven
Vandeputte, Caroline
Maetens, Marion
Van den Eynde, Marc
Maréchal, Raphaël
Borbath, Ivan
Dresse, Damien
Houbiers, Ghislain
Fried, Michael
Awada, Ahmad
Piccart, Martine
Van Laethem, Jean-Luc
Flamen, Patrick
Dokumenttyp: Artikel
Erscheinungsdatum: 2015
Verlag/Hrsg.: BioMed Central Ltd.
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26529752
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/175953